Lung cancer
From Testiwiki
Revision as of 07:52, 30 June 2010 by Teemu R (talk | contribs) (Created page with 'Category:Health effects {{variable|moderator=Teemu R}} ==Scope== What is the incidence of lung cancer in the general population? ==Definition== {| {{prettytable}} | 375,000 …')
This page is a variable.
The page identifier is Op_en4536 |
---|
Moderator:Teemu R (see all) |
Give your opinion to the peer rating of the content of this page. |
Upload data
|
Scope
What is the incidence of lung cancer in the general population?
Definition
375,000 cases (estimate) | ||||||||||
303,000 in men | ||||||||||
72,000 in women | ||||||||||
Estimated number of resulting deaths = 347,000 (280,000 in men and 67,000 in women). | ||||||||||
Estimates of lung-cancer incidence in Europe, 2000 | ||||||||||
Men | Women | |||||||||
Country | Crude rate | ASR | Cumulative risk* | No of cases | Crude rate | ASR | Cumulative risk* | No of cases | ||
Eastern Europe | 87.2 | 69•7 | 4•4 | 126 653 | 79•2 | 63•1 | 3•8 | 115 091 | ||
Northern Europe | 73.5 | 44•3 | 1•9 | 33 976 | 75•7 | 45•1 | 1•8 | 35 007 | ||
Southern Europe | 95.9 | 58•8 | 3•2 | 67 518 | 84•4 | 50•4 | 2•5 | 59 426 | ||
Western Europe | 83.9 | 53•2 | 2•9 | 75 350 | 79•1 | 48•9 | 2•3 | 71 024 | ||
*Cumulative risks are for ages 0–64 years. ASR, age-standardised rate. | ||||||||||
Europe, 2000 | J.Tyczynski, F.Bray, D.Maxwell Parkin. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. The Lancet Oncology, Volume 4, Issue 1, Pages 45-55. | |||||||||
Relative risk of lung cancer in European men and women | ||||||||||
Men | Women | |||||||||
Squamous-cell | ||||||||||
and small-cell | ||||||||||
carcinoma | Adenocarcinoma | Squamous-cell | ||||||||
and small-cell | ||||||||||
carcinoma | Adenocarcinoma | |||||||||
Non-smoker | 1•0 | 1•0 | 1•0 | 1•0 | ||||||
Ex-smoker | 16•2* | 3•5* | 3•8* | 1•1 | ||||||
Current smoker | 57•9* | 8•0* | 18•2* | 4•1* | ||||||
* p<0•05 | ||||||||||
Table 2. Effects of smoking cessation on lung-cancer risk | ||||||||||
Relative risk | ||||||||||
Time since stopping | Men | Women | ||||||||
Current smokers | 1•00 | 1•00 | ||||||||
2–9 years | 0•66* | 0•41* | ||||||||
10–19 years | 0•27* | 0•19* | ||||||||
20–29 years | 0•17* | 0•08* | ||||||||
>30 years | 0•08* | 0•13* | ||||||||
Non-smokers | 0•04* | 0•11* | ||||||||
* p<0•05 | ||||||||||
n=7,609 with 10,431 controls, 10 case-control studies of lung cancer in 6 | ||||||||||
countries from 1988 to 1994: Sweden, Germany, United Kingdom, | ||||||||||
France, Spain, Italy. Lung cancer | Simonato L, Agudo A, Ahrens W, et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 2001; 91: 876–87. | |||||||||
Number of new cases and rates of lung cancer, UK, 2006 | ||||||||||
England | Wales | Scotland | N.Ireland | UK | ||||||
Cases | ||||||||||
Males | 18,026 | 1,299 | 2,509 | 547 | 22,381 | |||||
Females | 13,141 | 984 | 2,177 | 344 | 16,646 | |||||
Persons | 31,167 | 2,283 | 4,686 | 891 | 39,027 | |||||
Crude rate per 100,000 population | ||||||||||
Males | 72.3 | 89.9 | 101.6 | 64.1 | 75.4 | |||||
Females | 50.9 | 64.7 | 82.2 | 38.7 | 53.9 | |||||
Persons | 61.4 | 77.0 | 91.6 | 51.2 | 64.4 | |||||
Age-standardised rate (European) per 100,000 population | ||||||||||
Males | 58.3 | 65.8 | 81.7 | 60.8 | 60.8 | |||||
95% CI | 57.5 | 59.2 | 62.2 | 69.4 | 78.5 | 84.9 | 55.7 | 65.9 | 60.0 | 61.5 |
Females | 35.0 | 40.9 | 55.1 | 31.5 | 37.1 | |||||
95% CI | 34.4 | 35.6 | 38.3 | 43.4 | 52.8 | 57.4 | 28.2 | 34.9 | 36.5 | 37.6 |
Persons | 45.2 | 51.9 | 66.2 | 44.3 | 47.4 | |||||
95% CI | 44.7 | 45.7 | 49.8 | 54.0 | 64.3 | 68.1 | 41.4 | 47.2 | 46.9 | 47.9 |
UK, 2006, lunch cancer | Doctor diagnosed | http://info.cancerresearchuk.org/cancerstats/types/lung/incidence/index.htm | ||||||||
INCIDENCE | MORTALITY | |||||||||
MALE | FEMALE | MALE | FEMALE | |||||||
ASR | Cumulative risk | ASR | Cumulative risk | ASR | Cumulative risk | ASR | Cumulative risk | |||
(World) | (age 0–64) | (World) | (age 0-64) | (World) | (age 0–64) | (World) | (age 0-64) | |||
E. Europe | 257.7 | 14.1 | 175.1 | 10.8 | 197.2 | 10.4 | 101.9 | 5.6 | ||
N. Europe | 283.1 | 11.7 | 252.3 | 14.0 | 161.0 | 5.8 | 118.1 | 5.2 | ||
S. Europe | 299.4 | 14.2 | 208.1 | 12.0 | 170.1 | 7.1 | 92.2 | 4.2 | ||
W. Europe | 326.4 | 15.5 | 244.6 | 14.1 | 173.9 | 7.0 | 106.1 | 4.6 | ||
World | 209.6 | 10.3 | 161.5 | 9.5 | 137.7 | 6.4 | 92.1 | 4.9 | ||
Worldwide, 1993-2001 with population estimates from 2002 to estimate 2002 cancer burden, from GLOBOCAN database, lung cancer | D. Max Parkin, Freddie Bray, J. Ferlay and Paola Pisani. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005;55;74-108 | |||||||||
Total prevalence by country and age class. Proportions per 100000 persons | ||||||||||
Men | Women | |||||||||
0-44 | 45-64 | 65+ | All ages | 0-44 | 45-64 | 65+ | All ages | |||
Netherlands | 3.3 | 276.5 | 1468.0 | 197.4 | 3.1 | 79.3 | 101.1 | 33.1 | ||
Germany | 5.6 | 246.5 | 907.4 | 168.0 | 2.3 | 51.3 | 100.1 | 33.1 | ||
Austria | 5.7 | 201.5 | 610.0 | 103.1 | 3.9 | 68.9 | 111.1 | 33.9 | ||
Switzerland | 6.4 | 215.0 | 721.6 | 145.8 | 3.4 | 71.6 | 144.0 | 45.9 | ||
Slovenia | 7.5 | 262.1 | 672.0 | 118.9 | 1.5 | 36.1 | 60.5 | 17.8 | ||
Slovakia | 6.3 | 398.6 | 1390.4 | 206.5 | 2.0 | 40.3 | 141.5 | 28.1 | ||
Poland | 5.5 | 216.2 | 424.5 | 100.0 | 2.9 | 57.3 | 103.9 | 32.6 | ||
All Euro countries (n=17) | 3.8 | 201.5 | 791.5 | 144.1 | 2.2 | 59.7 | 166.1 | 44.2 | ||
Austria, Germany, The Netherlands, Poland, Slovakia, Slovenia and Switzerland, 1970-1992, lung cancer | J. M. Lutz, S. Francisci, E. Mugno, M. Usel, V. Pompe-Kirn, J.-W. Coebergh & M. Bieslka-Lasota. Cancer prevalence in Central Europe: the EUROPREVAL Study. Annals of Oncology, 2003, 14: 313–322. |
Result
See also
Related files
<mfanonymousfilelist></mfanonymousfilelist>